Researchers at RUSH are leading efforts to cure disease and promote health equity — in Chicago and around the world. Our students and faculty work together on the frontiers of clinical, basic science and community-based research, in order to improve care for patients at RUSH and beyond.
RUSH has received $5 million from the Foundation for Angelman Syndrome Therapeutics to establish a center for clinical trials and translational research for rare neurodevelopmental disorders. The RUSH F.A.S.T. Center for Translational Research will be the global headquarters for training young investigators.
New research published in Neurology continues a legacy of work examining the association between Alzheimer’s dementia and flavonoids. The study suggests dietary intake of flavonols may be associated with slower decline in cognitive abilities. Read more
Co-led by RUSH and the University of Chicago, the Institute for Translational Medicine was launched in 2018 to drive research breakthroughs and bring those discoveries into the real world to improve health as soon as possible. Read more
Faraz Bishehsari, MD, PhD, received the NIH’s prestigious Director’s Transformative Research Award for his work focused on developing new methods to discover treatments for pancreatic cancer. Read more
